Spanish Red Biotech Pipeline

Merck KGaA

Tepotinib (MET kinase inhibitor)

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Non-small cell lung cancer, EGFR mutant, MET amplified
Phase: 2Phase II in Spain, 1Phase I